Todd E. Golde, MD, PhD


Titles and Roles

Professor, Department of Pharmacology and Chemical Biology
Emory University School of Medicine
Professor, Department of Neurology
Emory University School of Medicine
Goizueta Institute @ Emory Brain Health
Research Program
Discovery and Developmental Therapeutics


Todd E. Golde, MD, PhD, is director of the Emory Center for Neurodegenerative Disease in the Goizueta Institute @ Emory Brain Health. A Georgia Research Alliance (GRA) Eminent Scholar in Neuroscience, Dr. Golde holds a primary faculty appointment as professor in the Department of Pharmacology and Chemical Biology and a secondary appointment in the Department of Neurology at Emory University School of Medicine.

An international expert in the scientific understanding of Alzheimer's disease and other neurodegenerative diseases, he works to expand Emory's translational research for the development of new therapeutics for neurodegenerative diseases, while facilitating interdisciplinary research in neuroinflammation, bridging the neuroscience and immunology communities.

Prior to arriving at Emory, Dr. Golde was a professor of neuroscience and neurology at the University of Florida and director of the Evelyn F. and William L. McKnight Brain Institute. He was also a founding director of the 1Florida Alzheimer's Disease Research Center, a consortium of leading Florida institutions supported by the National Institutes of Health.


Dr. Golde earned his PhD in pathology and his MD at Case Western Reserve University in Cleveland, Ohio, where he also completed a postdoctoral fellowship. He completed a residency in clinical pathology at University of Pennsylvania in Philadelphia, Pennsylvania.


Dr. Golde's Alzheimer's disease research helped lay the foundation for the amyloid hypothesis and has made major contributions to the understanding of amyloid and tau pathologies, as well as the immune system's role in the disease. In an effort to develop innovative new therapies to combat Alzheimer's disease (AD), his laboratory is exploring a large number of proteins that accumulate alongside amyloid; investigating the use of antibodies to target psychological stress pathways, thought to contribute to AD and many other diseases; and evaluating ways in which the immune system might be harnessed for beneficial effects in AD.


Dr. Golde's research laboratory has produced 310 publications cited approximately 43,000 times and has been awarded more than $65 million in NIH grants since 2000. He is an inventor on over 15 patents and patent applications and is a co-founder of two biotech companies.

  • PublicationsPublication Date

Additional Websites

Cascade Link   TOP